¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"myelin degeneration"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hydropic degeneration
    ¼öÆ÷º¯¼º
  • lattice degeneration
    °ÝÀÚº¯¼º
  • liquefaction degeneration
    ¾×È­º¯¼º
  • malignant degeneration
    ¾Ç¼ºº¯¼º
  • myopic degeneration
    ±Ù½Ãº¯¼º
  • microcystic degeneration
    ¹Ì¼¼³¶º¯¼º
  • nodular colloid degeneration
    °áÀýÄÝ·ÎÀ̵庯¼º
  • postencephalitic degeneration
    ³ú¿°Èĺ¯¼º
  • parenchymatous degeneration
    ½ÇÁúº¯¼º
  • pallidal degeneration
    â¹éÇÙº¯¼º
  • red degeneration
    Àû»öº¯¼º
  • reticular degeneration
    ±×¹°º¯¼º, ¸Á»óº¯¼º
  • retrograde degeneration
    ¿ªÇຯ¼º, ¿ª¹æÇ⺯¼º
  • rim degeneration
    °¡ÀåÀÚ¸®º¯¼º, º¯¿¬º¯¼º
  • solar degeneration
    Àϱ¤º¯¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • endoglobular degeneration
    Ç÷±¸³»º¯¼º
  • equatorial degeneration
    Àûµµº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º
  • hydropic degeneration
    ¼öÆ÷º¯¼º
  • lattice degeneration
    °ÝÀÚº¯¼º
  • liquefaction degeneration
    ¾×È­º¯¼º
  • malignant degeneration
    ¾Ç¼ºº¯¼º
  • microcystic degeneration
    ¹Ì¼¼³¶º¯¼º
  • myopic degeneration
    ±Ù½Ãº¯¼º
  • nodular colloid degeneration
    °áÀý±³Áúº¯¼º
  • pallidal degeneration
    â¹éÇÙº¯¼º
  • parenchymatous degeneration
    ½ÇÁúº¯¼º
  • red degeneration
    Àû»öº¯¼º
  • reticular degeneration
    ±×¹°º¯¼º
  • retrograde degeneration
    ¿ªÇຯ¼º, ¿ª¹æÇ⺯¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pigmentary retinal degeneration
    ¸Á¸·»ö¼Òº¯¼º(Áõ).(ØÑدßäáÈܨàõ(ñø))
  • posterolateral degeneration of spinal cord
    ô¼öÈÄÃø¼º º¯¼º(ô±âÐý­ö°àõܨ àõ).
  • posterolateral degeneration of spinal cord
    ô¼öÈÄÃø¼º º¯¼º(ô±âÐý­ö°àõ ܨàõ)
  • primary degeneration
    ÀÏÂ÷º¯¼º(ìéó­Ü¨àõ)
  • progressive lenticular degeneration
    ÁøÇ༺ ·»ÁîÇÙº¯¼º(Áõ)(òäú¼àõ¡­ú·Ü¨àõ(ñø))
  • pyramidal degeneration
    Ãßüº¯¼º(õÞô÷ܨàõ)
  • red degeneration
    Àû»öº¯¼º(îåßäܨàõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • myelin sheath
    ¼öÃÊ(âÐôú)
  • actinic degeneration
    ±¤¼±(ÎÃàÊ) º¯¼º(ܨàõ)
  • age-related macular degeneration
    ¿¬·É°ü·ÃȲ¹Ýº¯¼º, ³ë³â±âȲ¹Ýº¯¼º
  • alcoholic cerebellar degeneration
    ¾ËÄڿüº ¼Ò³úº¯¼º(¡­á³Òàܨàõ).
  • amyloid degeneration
    ¾Æ¹Ð·ÎÀ̵庯¼º(¡­Ü¨àõ).
  • angiolithic degeneration
    ¸Æ°ü°á¼®¼º º¯¼º(ØæÎ·Ì¿à´àõܨàõ).
  • ballooning degeneration
    dz¼±º¯¼º
  • basophilic degeneration
    È£¿°±â¼º º¯¼º(¡­Ü¨àõ)
  • calcareous corneal degeneration
    ¼®È¸°¢¸·º¯¼º
  • cell,hydropic degeneration
    ¼öÆ÷¼º º¯¼º(â©øÜàõܨà÷)
  • cerebellar degeneration
    ¼Ò³úº¯¼º
  • cerebellar degeneration
    ¼Ò³úº¯¼º(¡­Ü¨àõ)
  • cerebromacular degeneration
    ³úȲ¹Ýº¯¼º(Áõ).
  • cobblestone degeneration
    ÀÚ°¥¸ð¾çº¯¼º, Æ÷¼®»óº¯¼º
  • corneal degeneration
    °¢¸·º¯¼º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ATM abnormal tubular myelin; acute transverse myelopathy; asynchronous transfer mode; atmosphere
MAG myelin-associated glycoprotein
MBP major basic protein; maltose-binding protein; management by policy; mannose-binding protein; mean bl...
MF magnetic field; meat free; medium frequency; megafarad; membrane filler; merthiolate-formaldehyde [s...
MOG myelin-oligodendrocyte glycoprotein
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MOG Myelin Oligodendrocyte Glycoprotein
MAG Myelin associated glycoprotein
MOBP Myelin-associated oligodendrocytic basic protein
mld Myelin-deficient
PMP-22 Peripheral Myelin Protein-22
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cystic degeneration
    ³¶»ó º¯¼º, ³¶Á¾ º¯¼º
  • cystoid degeneration
    À¯³¶»ó º¯¼º
  • degeneration of pulp
    Ä¡¼öÀÇ ÅðÈ­
    ³ëÈ­ µîÀÇ ¿µÇâÀ¸·Î Ä¡¼ö°¡ À§ÃàµÇ°í Ä¡¼ö°­ÀÌ Á¼¾ÆÁö´Â °Í.
  • disk degeneration
    ¿øÆÇ º¯¼º
  • fat degeneration
    Áö¹æ º¯¼º
  • fibrinoid degeneration
    ¼¶À¯¼Ò¾ç º¯¼º, ¼¶À¯¾ç º¯¼º
    µ¿ÀǾî=fibrinoid swelling.
  • hyaline degeneration
    À¯¸®Áú º¯¼º
    ¼¼Æ÷ÁúÀÌ ±ÕÁúÀÌ À¯¸® ¸ð¾çÀΠȣ»ê¼ºÀÇ ¸ð¾çÀ» ³ªÅ¸³»´Â ÅðÇ༺ ¼¼Æ÷ º¯È­.
  • joint degeneration
    °üÀý ÅðÇà
  • liquefactive degeneration
    ¾×È­ º¯¼º
  • malignant degeneration
    ¾Ç¼ºÈ­
  • mosaic corneal degeneration
    ¸ðÀÚÀÌÅ© °¢¸· º¯¼º
  • myocardial degeneration
    ½É±Ù º¯¼º
  • myopic degeneration
    ±Ù½Ã¼º º¯¼º
  • neurologic degeneration
    ½Å°æ¼º ÅðÃà
  • Nissl's degeneration
    ´Ï½½ º¯¼º
    ½Å°æ ¼¶À¯ Àý´Ü ÈÄ¿¡ ÀϾ´Â ½Å°æÀý ¼¼Æ÷ÀÇ º¯¼º.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
age-related macular degeneration A common macular degeneration beginning with drusen of the macula and pigment disruption and sometimes leading to severe loss of central vision.
(05 Mar 2000)
albuminous degeneration An obsolete terms for cloudy swelling.
(05 Mar 2000)
amyloid degeneration Infiltration of amyloid between cells and fibres of tissues and organs.
Synonym: waxy degeneration.
(05 Mar 2000)
angiolithic degeneration Calcareous degeneration of the walls of the blood vessels.
(05 Mar 2000)
ascending degeneration Retrograde degeneration of an injured nerve fibre; i.e., toward the nerve cell of the fibre, degeneration cephalad to a spinal cord lesion.
(05 Mar 2000)
atheromatous degeneration Focal accumulation of lipid material (atheroma) in the intima and subintimal portion of arteries, eventually resulting in fibrous thickening or calcification.
(05 Mar 2000)
axonal degeneration A type of peripheral nerve fibre response to insult, wherein axon death and subsequent breakdown occurs, with secondary breakdown of the myelin sheath associated; caused by focal injury to peripheral nerve fibres; often referred to as wallerian degeneration.
Synonym: axon degeneration.
(05 Mar 2000)
axon degeneration A type of peripheral nerve fibre response to insult, wherein axon death and subsequent breakdown occurs, with secondary breakdown of the myelin sheath associated; caused by focal injury to peripheral nerve fibres; often referred to as wallerian degeneration.
Synonym: axon degeneration.
(05 Mar 2000)
ballooning degeneration A phenomenon observed especially in cells that are infected with certain viruses, resulting in conspicuous swelling of the cell and cytoplasmic vacuolation.
(05 Mar 2000)
basophilic degeneration Blue staining of connective tissues when haematoxylin-eosin stain is used; found in such conditions as solar elastosis.
(05 Mar 2000)
calcareous degeneration In a precise sense, not a degenerative process per se, but the deposition of insoluble calcium salts in tissue that has degenerated and become necrotic, as in dystrophic calcification.
(05 Mar 2000)
carneous degeneration Necrosis, with staining by haemoglobin, which may occur in uterine myomas, especially during pregnancy; marked by softening and a red colour resembling partly cooked meat.
Synonym: carneous degeneration.
(05 Mar 2000)
vacuolar degeneration Formation of nonlipid vacuoles in cytoplasm, most frequently due to accumulation of water by cloudy swelling.
(05 Mar 2000)
macular degeneration <ophthalmology> Breakdown or damage to a portion of the retina known as the macula.
Symptoms include blurring of vision (in central visual field), colours appear dim and difficulty reading or performing work up close.
(27 Sep 1997)
reaction of degeneration The electrical reaction in a degenerated nerve and the muscles supplied by it; characterised by absence of response to both galvanic and faradic stimulus in the nerve and to faradic stimulus in the muscles; the muscles may still respond to galvanic stimulation, but the cathodal closing contraction is greater than the anodal closing contraction, the reverse of normal.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á